drugset / Trial / NCT02572323
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Phase 2
Completed
73 enrolled
University of California, San Diego
PalmTree Clinical Research Inc. · collabUniversity of California, San Francisco · collabUniversity of Southern California · collab
RandomizedCrossoverSingle-blindTreatment
Summary
The aim of this study is to test whether tesamorelin, in combination with a text-messaging application to help with motivation and adherence, will significantly improve memory and thinking in HIV.
Timeline
- Start
- 2017-02-15
- Primary completion
- 2023-10-15
- Completion
- 2023-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tesamorelin | Peptide | 1.4 mg | Other |